Hai Lin

1.6k citations

41 papers · 1.1k indexed · h-index 19

Co-authors: Yubin Ge Holly Edwards Jeffrey W. Taub Guan Wang Jianyun Zhao Jun Ma Xiaojia Niu Yongwei Su
Topics: Acute Myeloid Leukemia Research (21 papers)Cell death mechanisms and regulation (11 papers)Histone Deacetylase Inhibitors Research (11 papers)
Cited by: Hematology Genetics Molecular Biology
Journals: Nature Communications Blood Scientific Reports
Partner nations: China United States Saint Kitts and Nevis

In The Last Decade

Hai Lin

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hai Lin

Since Specialization

Citations

This map shows the geographic impact of Hai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Lin more than expected).

Fields of papers citing papers by Hai Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Lin. The network helps show where Hai Lin may publish in the future.

Co-authorship network of co-authors of Hai Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Lin. A scholar is included among the top collaborators of Hai Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Lin. Hai Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia 2022 ·Journal of Cellular and Molecular Medicine ·(unknown),(unknown),Shuang Liu,Xinyu Li,(unknown),Hai Lin,Yue Wang,Holly Edwards,Yubin Ge,Guan Wang	16
2	c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia 2022 ·APOPTOSIS ·Shuang Liu,(unknown),(unknown),(unknown),Yongwei Su,Holly Edwards,Yue Wang,Hai Lin,Jeffrey W. Taub,Guan Wang,Yubin Ge	16
3	Measurable residual disease detected by flow cytometry independently predicts prognoses of NPM1-mutated acute myeloid leukemia 2022 ·Annals of Hematology ·(unknown),Long Su,Yehui Tan,Hai Lin,Xiaoliang Liu,(unknown),Jingnan Sun,(unknown),(unknown),Fei Song,Wei Han,Sujun Gao	0
4	The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy 2022 ·Frontiers in Oncology ·(unknown),(unknown),Xiaoling Zhang,Hai Lin,Qiuju Liu	4
5	The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML 2021 ·Blood Cancer Journal ·(unknown),Jun Ma,Tristan Knight,Yongwei Su,Holly Edwards,Lisa Polin,Jing Li,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Jian Wang,Hai Lin,Yue Wang,(unknown),Guan Wang,Jeffrey W. Taub,Yubin Ge	27
6	Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance 2021 ·Experimental Hematology ·Fangbing Liu,(unknown),Yongwei Su,Jing Lv,(unknown),Shuang Liu,Hai Lin,Yue Wang,Guan Wang	13
7	Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia 2020 ·Signal Transduction and Targeted Therapy ·Daniel A Luedtke,Yongwei Su,Jun Ma,Xinyu Li,Steven Buck,Holly Edwards,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Hai Lin,Jeffrey W. Taub,Yubin Ge	50
8	Shuangshen granules attenuate lung metastasis by modulating bone marrow differentiation through mTOR signalling inhibition 2020 ·Journal of Ethnopharmacology ·(unknown),(unknown),Ruili Zhu,Cong-En Zhang,(unknown),Rui Liu,Baojin Hua,Yangfan Li,Hai Lin,Jing Yu	18
9	Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia 2019 ·Clinical Cancer Research ·Jun Ma,(unknown),(unknown),Tristan Knight,Holly Edwards,Lisa Polin,Juiwanna Kushner,Sijana H. Dzinic,Kathryn White,Guan Wang,Lijing Zhao,Hai Lin,Yue Wang,Jeffrey W. Taub,Yubin Ge	117
10	Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemia 2019 ·Signal Transduction and Targeted Therapy ·Tingting Wang,(unknown),Fangbing Liu,Tristan Knight,Holly Edwards,Guan Wang,Hai Lin,Yue Wang,Jeffrey W. Taub,Yubin Ge	4
11	CSF3R mutations were associated with an unfavorable prognosis in patients with acute myeloid leukemia with CEBPA double mutations 2019 ·Annals of Hematology ·Long Su,Sujun Gao,Yehui Tan,Hai Lin,Xiao‐Liang Liu,Shanshan Liu,Yan Yang,Jingnan Sun,Wei Li	22
12	Inhibition of XPO1 enhances cell death induced by ABT‐199 in acute myeloid leukaemia via Mcl‐1 2018 ·Journal of Cellular and Molecular Medicine ·Daniel A Luedtke,Yongwei Su,Shuang Liu,Holly Edwards,Yue Wang,Hai Lin,Jeffrey W. Taub,Yubin Ge	46
13	An unexpected protein interaction promotes drug resistance in leukemia 2017 ·Nature Communications ·Aaron Pitre,Yubin Ge,Wenwei Lin,Yao Wang,Yu Fukuda,Jamshid Temirov,Aaron H. Phillips,Jennifer L. Peters,Yiping Fan,Jing Ma,Amanda Nourse,Chandrima Sinha,Hai Lin,Richard W. Kriwacki,James R. Downing,Tanja A. Grüber,Victoria E. Centonze,Anjaparavanda P. Naren,Taosheng Chen,John D. Schuetz	20
14	Inhibition of XPO1 By KPT-330 (Selinexor) Enhances Cell Death Induced By the Bcl-2 Selective Inhibitor ABT-199 (Venetoclax) through Downregulation of Mcl-1 in Acute Myeloid Leukemia 2017 ·Blood ·Daniel A Luedtke,Yongwei Su,Holly Edwards,Hai Lin,Jeffrey W. Taub,Yubin Ge	3
15	Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo 2017 ·Biochemical Pharmacology ·Yongwei Su,Xinyu Li,Jun Ma,Jianyun Zhao,Shuang Liu,Guan Wang,Holly Edwards,Jeffrey W. Taub,Hai Lin,Yubin Ge	39
16	Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells 2017 ·Signal Transduction and Targeted Therapy ·Daniel A Luedtke,Xiaojia Niu,Yihang Pan,Jianyun Zhao,Shuang Liu,Holly Edwards,Kang Chen,Hai Lin,Jeffrey W. Taub,Yubin Ge	101
17	Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells 2016 ·Clinical Cancer Research ·Xiaojia Niu,Jianyun Zhao,Jun Ma,Chengzhi Xie,Holly Edwards,Guan Wang,J. Timothy Caldwell,Shengyan Xiang,Xiaohong Zhang,Roland Chu,Zhihong J. Wang,Hai Lin,Jeffrey W. Taub,Yubin Ge	181
18	Eosinophilic Fasciitis following Allogeneic Bone Marrow Transplantation in a Patient with Acute Myeloid Leukaemia 2014 ·Acta Dermato Venereologica ·(unknown),Hai Lin,Gang Chen,Ching‐Ying Wu	5
19	A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations 2014 ·Leukemia ·Liang Zhou,Yuesheng Zhang,(unknown),Maciej Kmieciak,Yun Leng,Hai Lin,Kathryn Rizzo,Catherine I. Dumur,Andrea Ferreira‐Gonzalez,Yun Dai,Steven Grant	63
20	Analysis of the efficacy of lenalidomide in patients with intermediate-1 risk myelodysplastic syndrome without 5q deletion 2013 ·Experimental and Therapeutic Medicine ·Yan Yang,Sujun Gao,(unknown),Hai Lin,Wei Li,Juan Wang	1

About Hai Lin

Hai Lin is a scholar working on Hematology, Genetics and Molecular Biology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Cell death mechanisms and regulation (11 papers) and Histone Deacetylase Inhibitors Research (11 papers). The work is most often cited by research in Hematology (621 citations), Genetics (158 citations) and Molecular Biology (838 citations). Hai Lin has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Yubin Ge, Holly Edwards, Jeffrey W. Taub, Guan Wang, Jianyun Zhao, Jun Ma, Xiaojia Niu, Yongwei Su, Daniel A Luedtke and Chengzhi Xie. Their work appears in journals such as Nature Communications, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact